Top

Published in:

Open Access 01-02-2018 | Clinical trial

Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial

Authors: Sara Mijwel, Malin Backman, Kate A. Bolam, Anna Jervaeus, Carl Johan Sundberg, Sara Margolin, Maria Browall, Helene Rundqvist, Yvonne Wengström

Published in: Breast Cancer Research and Treatment | Issue 1/2018

Abstract

Purpose

Exercise training is an effective and safe way to counteract cancer-related fatigue (CRF) and to improve health-related quality of life (HRQoL). High-intensity interval training has proven beneficial for the health of clinical populations. The aim of this randomized controlled trial was to compare the effects of resistance and high-intensity interval training (RT–HIIT), and moderate-intensity aerobic and high-intensity interval training (AT–HIIT) to usual care (UC) in women with breast cancer undergoing chemotherapy. The primary endpoint was CRF and the secondary endpoints were HRQoL and cancer treatment-related symptoms.

Methods

Two hundred and forty women planned to undergo chemotherapy were randomized to supervised RT–HIIT, AT–HIIT, or UC. Measurements were performed at baseline and at 16 weeks. Questionnaires included Piper Fatigue Scale, EORTC-QLQ-C30, and Memorial Symptom Assessment Scale.

Results

The RT–HIIT group was superior to UC for CRF: total CRF (p = 0.02), behavior/daily life (p = 0.01), and sensory/physical (p = 0.03) CRF. Role functioning significantly improved while cognitive functioning was unchanged for RT–HIIT compared to declines shown in the UC group (p = 0.04). AT–HIIT significantly improved emotional functioning versus UC (p = 0.01) and was superior to UC for pain symptoms (p = 0.03). RT–HIIT reported a reduced symptom burden, while AT–HIIT remained stable compared to deteriorations shown by UC (p < 0.01). Only RT–HIIT was superior to UC for total symptoms (p < 0.01).

Conclusions

16 weeks of resistance and HIIT was effective in preventing increases in CRF and in reducing symptom burden for patients during chemotherapy for breast cancer. These findings add to a growing body of evidence supporting the inclusion of structured exercise prescriptions, including HIIT, as a vital component of cancer rehabilitation.

Trial registration

Clinicaltrials.gov Registration Number: NCT02522260.

Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (Lond, Engl) 379(9814):432–444. https://doi.org/10.1016/s0140-6736(11)61625-5 CrossRef

Barbaric M, Brooks E, Moore L, Cheifetz O (2010) Effects of physical activity on cancer survival: a systematic review. Physiother Can 62(1):25–34. https://doi.org/10.3138/physio.62.1.25 CrossRefPubMedPubMedCentral

Davies NJ, Batehup L, Thomas R (2011) The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer 105(Suppl 1):S52–S73. https://doi.org/10.1038/bjc.2011.423 CrossRefPubMedPubMedCentral

Bower JE (2014) Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597–609. https://doi.org/10.1038/nrclinonc.2014.127 CrossRefPubMedPubMedCentral

van Vulpen JK, Peeters PH, Velthuis MJ, van der Wall E, May AM (2016) Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue: a meta-analysis. Maturitas 85:104–111. https://doi.org/10.1016/j.maturitas.2015.12.007 CrossRefPubMed

Medysky ME, Temesi J, Culos-Reed SN, Millet GY (2017) Exercise, sleep and cancer-related fatigue: are they related? Clin Neurophysiol 47(2):111–122. https://doi.org/10.1016/j.neucli.2017.03.001 CrossRef

Casla S, Lopez-Tarruella S, Jerez Y, Marquez-Rodas I, Galvao DA, Newton RU, Cubedo R, Calvo I, Sampedro J, Barakat R, Martin M (2015) Supervised physical exercise improves VO_2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Res Treat 153(2):371–382. https://doi.org/10.1007/s10549-015-3541-x CrossRefPubMed

Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R (2015) Supervised exercise reduces cancer-related fatigue: a systematic review. J Physiother 61(1):3–9. https://doi.org/10.1016/j.jphys.2014.08.019 CrossRefPubMed

Mustian KM, Alfano CM, Heckler C et al (2017) Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 3(7):961–968. https://doi.org/10.1001/jamaoncol.2016.6914 CrossRefPubMedPubMedCentral

10.

Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, Yasui Y, McKenzie DC (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404. https://doi.org/10.1200/jco.2006.08.2024 CrossRefPubMed

11.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL, Medicine A (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426. https://doi.org/10.1249/MSS.0b013e3181e0c112 CrossRefPubMed

12.

Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slordahl SA, Kemi OJ, Najjar SM, Wisloff U (2008) Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118(4):346–354. https://doi.org/10.1161/circulationaha.108.772822 CrossRefPubMedPubMedCentral

13.

Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115(24):3086–3094. https://doi.org/10.1161/circulationaha.106.675041 CrossRefPubMed

14.

Jaureguizar KV, Vicente-Campos D, Bautista LR, de la Pena CH, Gomez MJ, Rueda MJ, Fernandez Mahillo I (2016) Effect of high-intensity interval versus continuous exercise training on functional capacity and quality of life in patients with coronary artery disease: a randomized clinical trial. J Cardiopulm Rehabil Prev 36(2):96–105. https://doi.org/10.1097/hcr.0000000000000156 CrossRefPubMed

15.

Thum JS, Parsons G, Whittle T, Astorino TA (2017) High-intensity interval training elicits higher enjoyment than moderate intensity continuous exercise. PLoS ONE 12(1):e0166299. https://doi.org/10.1371/journal.pone.0166299 CrossRefPubMedPubMedCentral

16.

Ouerghi N, Selmi O, Ben Khalifa W, Ben Fradj MK, Feki M, Kaabachi N, Bouassida A (2016) Effect of high-intensity intermittent training program on mood state in overweight/obese young men. Iran J Public Health 45(7):951–952PubMedPubMedCentral

17.

Drigny J, Gremeaux V, Dupuy O, Gayda M, Bherer L, Juneau M, Nigam A (2014) Effect of interval training on cognitive functioning and cerebral oxygenation in obese patients: a pilot study. J Rehabil Med 46(10):1050–1054. https://doi.org/10.2340/16501977-1905 CrossRefPubMed

18.

Saanijoki T, Tuominen L, Tuulari JJ, Nummenmaa L, Arponen E, Kalliokoski K, Hirvonen J (2017) Opioid release after high-intensity interval training in healthy human subjects. Neuropsychopharmacology. https://doi.org/10.1038/npp.2017.148 PubMed

19.

Schmitt J, Lindner N, Reuss-Borst M, Holmberg HC, Sperlich B (2016) A 3-week multimodal intervention involving high-intensity interval training in female cancer survivors: a randomized controlled trial. Physiol Rep. https://doi.org/10.14814/phy2.12693 PubMedPubMedCentral

20.

Dolan LB, Campbell K, Gelmon K, Neil-Sztramko S, Holmes D, McKenzie DC (2016) Interval versus continuous aerobic exercise training in breast cancer survivors: a pilot RCT. Support Care Cancer 24(1):119–127. https://doi.org/10.1007/s00520-015-2749-y CrossRefPubMed

21.

Schulz SVW, Laszlo R, Otto S, Prokopchuk D, Schumann U, Ebner F, Huober J, Steinacker JM (2017) Feasibility and effects of a combined adjuvant high-intensity interval/strength training in breast cancer patients: a single-center pilot study. Disabil Rehabil. https://doi.org/10.1080/09638288.2017.1300688 PubMed

22.

Green N, Wertz T, LaPorta Z, Mora A, Serbas J, Astorino TA (2017) Comparison of acute physiological and psychological responses between moderate intensity continuous exercise and three regimes of high intensity training. J Strength Cond Res. https://doi.org/10.1519/JSC.0000000000002154

23.

Wengström Y, Bolam KA, Mijwel S, Sundberg CJ, Backman M, Browall M, Norrbom J, Rundqvist H (2017) Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy. BMC Cancer 17(1):100. https://doi.org/10.1186/s12885-017-3079-x CrossRefPubMedPubMedCentral

24.

Börjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, Heidbuchel H, Björnstad HH, Gielen S, Mezzani A, Corrado D, Pelliccia A, Vanhees L (2011) Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 18(3):446–458. https://doi.org/10.1097/HJR.0b013e32833bo969 CrossRefPubMed

25.

Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381CrossRefPubMed

26.

Mayhew JL, Prinster JL, Ware JS, Zimmer DL, Arabas JR, Bemben MG (1995) Muscular endurance repetitions to predict bench press strength in men of different training levels. J Sports Med Phys Fitness 35(2):108–113PubMed

27.

Jakobsson S, Taft C, Östlund U, Ahlberg K (2013) Performance of the Swedish version of the Revised Piper Fatigue Scale. Eur J Oncol Nurs 17(6):808–813. https://doi.org/10.1016/j.ejon.2013.07.004 CrossRefPubMed

28.

Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed

29.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRefPubMed

30.

Minton O, Stone P (2009) A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 20(1):17–25. https://doi.org/10.1093/annonc/mdn537 CrossRefPubMed

31.

Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, Mercier M, Tournier-Rangeard L, Leonard I, Montcuquet P, Rauch P, Conroy T (2011) Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 9:70. https://doi.org/10.1186/1477-7525-9-70 CrossRefPubMedPubMedCentral

32.

Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (Oxford, England: 1990) 30A(9):1326–1336CrossRef

33.

Browall M, Sarenmalm EK, Nasic S, Wengstrom Y, Gaston-Johansson F (2012) Validity and reliability of the Swedish Version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress. J Pain Symptom Manage. https://doi.org/10.1016/j.jpainsymman.2012.07.023 PubMed

34.

Snyder CF, Blackford AL, Brahmer JR, Carducci MA, Pili R, Stearns V, Wolff AC, Dy SM, Wu AW (2010) Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30. Qual Life Res 19(6):837–845. https://doi.org/10.1007/s11136-010-9636-2 CrossRefPubMed

35.

Aguilar-Farias N, Brown WJ, Peeters GM (2014) ActiGraph GT3X + cut-points for identifying sedentary behaviour in older adults in free-living environments. J Sci Med Sport 17(3):293–299. https://doi.org/10.1016/j.jsams.2013.07.002 CrossRefPubMed

36.

Morris SB (2007) Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods 11(2):364–386. https://doi.org/10.1177/1094428106291059 CrossRef

37.

Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Routledge, London

38.

Rubin LH, Witkiewitz K, Andre JS, Reilly S (2007) Methods for handling missing data in the behavioral neurosciences: don’t throw the baby rat out with the bath water. JUNE 5(2):A71–A77PubMedPubMedCentral

39.

van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK (2015) Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES Randomized Clinical Trial. J Clin Oncol 33(17):1918–1927. https://doi.org/10.1200/jco.2014.59.1081 CrossRefPubMed

40.

Mutrie N, Campbell AM, Whyte F, McConnachie A, Emslie C, Lee L, Kearney N, Walker A, Ritchie D (2007) Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ 334(7592):517. https://doi.org/10.1136/bmj.39094.648553.AE CrossRefPubMedPubMedCentral

41.

Campbell A, Mutrie N, White F, McGuire F, Kearney N (2005) A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment. Eur J Oncol Nurs 9(1):56–63. https://doi.org/10.1016/j.ejon.2004.03.007 CrossRefPubMed

42.

Adamsen L, Quist M, Andersen C, Moller T, Herrstedt J, Kronborg D, Baadsgaard MT, Vistisen K, Midtgaard J, Christiansen B, Stage M, Kronborg MT, Rorth M (2009) Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 339:b3410. https://doi.org/10.1136/bmj.b3410 CrossRefPubMedPubMedCentral

43.

McAuley E, Blissmer B, Katula J, Duncan TE, Mihalko SL (2000) Physical activity, self-esteem, and self-efficacy relationships in older adults: a randomized controlled trial. Ann Behav Med 22(2):131–139CrossRefPubMed

44.

Penninx BW, Rejeski WJ, Pandya J, Miller ME, Di Bari M, Applegate WB, Pahor M (2002) Exercise and depressive symptoms: a comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology. J Gerontol Ser B 57(2):P124–P132CrossRef

45.

Furmaniak AC, Menig M, Markes MH (2016) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd005001.pub3 PubMed

46.

Schmidt T, Weisser B, Durkop J, Jonat W, Van Mackelenbergh M, Rocken C, Mundhenke C (2015) Comparing endurance and resistance training with standard care during chemotherapy for patients with primary breast cancer. Anticancer Res 35(10):5623–5629PubMed

47.

Travier N, Velthuis MJ, Steins Bisschop CN, van den Buijs B, Monninkhof EM, Backx F, Los M, Erdkamp F, Bloemendal HJ, Rodenhuis C, de Roos MA, Verhaar M, ten Bokkel Huinink D, van der Wall E, Peeters PH, May AM (2015) Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. BMC Med 13:121. https://doi.org/10.1186/s12916-015-0362-z CrossRefPubMedPubMedCentral

48.

Lyon DE, Cohen R, Chen H, Kelly DL, Starkweather A, Ahn HC, Jackson-Cook CK (2016) The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study. J Cancer Res Clin Oncol 142(7):1461–1474. https://doi.org/10.1007/s00432-016-2163-y CrossRefPubMedPubMedCentral

49.

Saibil S, Fitzgerald B, Freedman OC, Amir E, Napolskikh J, Salvo N, Dranitsaris G, Clemons M (2010) Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol 17(4):42–47CrossRefPubMedPubMedCentral

50.

van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH (2016) Hyperalgesia and persistent pain after breast cancer surgery: a prospective randomized controlled trial with perioperative COX-2 inhibition. PLoS ONE 11(12):e0166601. https://doi.org/10.1371/journal.pone.0166601 CrossRefPubMedPubMedCentral

51.

Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98(9):1786–1801. https://doi.org/10.1002/cncr.11742 CrossRefPubMed

52.

Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Crawford JJ, Mackey JR (2014) Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc 46(9):1744–1751. https://doi.org/10.1249/mss.0000000000000297 CrossRefPubMed

53.

Wu HS, Harden JK (2015) Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 38(1):E29–E54. https://doi.org/10.1097/ncc.0000000000000135 CrossRefPubMed

54.

Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Cormie P, Bolam KA, Galvao DA (2017) Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. Eur Urol 72(2):293–299. https://doi.org/10.1016/j.eururo.2017.02.019 CrossRefPubMed

55.

Carayol M, Delpierre C, Bernard P, Ninot G (2015) Population-, intervention- and methodology-related characteristics of clinical trials impact exercise efficacy during adjuvant therapy for breast cancer: a meta-regression analysis. Psycho-oncology 24(7):737–747. https://doi.org/10.1002/pon.3727 CrossRefPubMed

Title: Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial
Authors: Sara Mijwel
Malin Backman
Kate A. Bolam
Anna Jervaeus
Carl Johan Sundberg
Sara Margolin
Maria Browall
Helene Rundqvist
Yvonne Wengström
Publication date: 01-02-2018
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4571-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting

Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer

Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES

Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer